Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000814460 | SCV000954871 | uncertain significance | Primary ciliary dyskinesia | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with glycine at codon 416 of the DRC1 protein (p.Ala416Gly). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and glycine. This variant is present in population databases (rs202052258, ExAC 0.05%). This variant has not been reported in the literature in individuals affected with DRC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 657775). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004972996 | SCV005576062 | uncertain significance | Inborn genetic diseases | 2024-08-26 | criteria provided, single submitter | clinical testing | The c.1247C>G (p.A416G) alteration is located in exon 10 (coding exon 10) of the DRC1 gene. This alteration results from a C to G substitution at nucleotide position 1247, causing the alanine (A) at amino acid position 416 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005029500 | SCV005655916 | uncertain significance | Primary ciliary dyskinesia 21; Spermatogenic failure 80 | 2024-01-30 | criteria provided, single submitter | clinical testing |